AKRO: Akero Therapeutics Inc

46.73 USD 0.21 (0.45%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do AKRO para hoje mudou para -0.45%. Paralelamente, o preço mais baixo no mercado atingiu 46.02 e o mais alto foi 47.34.

Veja a dinâmica do par de moedas Akero Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

AKRO Notícias

13:40 Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?
13:55 Does Akero Therapeutics (AKRO) Have the Potential to Rally 59.14% as Wall Street Analysts Expect?
15:13 RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study
21:45 Akero Therapeutics: Reversing My Contrarian Buy Rating To A Contrarian Sell Rating (AKRO)
15:11 Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus
22:54 Akero Therapeutics CEO Cheng sells $1.46 million in stock
22:51 Akero Therapeutics COO Young sells $597k in shares
00:45 Akero therapeutics director Henderson sells $142k in shares
13:40 Are Medical Stocks Lagging Akero Therapeutics (AKRO) This Year?
14:54 Akero Therapeutics stock strengthened as Morgan Stanley reiterates Overweight rating
10:22 Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary
18:36 Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH potential
18:35 Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH treatment potential
15:30 This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Akero Therapeutics (NASDAQ:AKRO), Apartment Inv & Mgmt (NYSE:AIV)
10:20 Janus Henderson Global Life Sciences Fund Q2 2025 Commentary (Mutual Fund:JAGLX)
12:46 Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect
16:10 Amarin Gears Up to Report Q2 Earnings: Here's What to Expect
15:42 Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
14:45 VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales
09:46 Altimmune: Potential Tough Road Ahead Amid Fierce Competition (Rating Downgrade) (ALT)
14:53 Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?
13:38 Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
15:28 RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
14:39 FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

Faixa diária

46.02 47.34

Faixa anual

21.34 58.40

Fechamento anterior: 46.94
Open: 47.01

Bid: 46.73
Ask: 47.03

Low: 46.02
High: 47.34

Volume: 1.002 K

Mudança diária: -0.45%
Mudança mensal: -3.49%

Mudança de 6 meses: -2.65%
Mudança anual: 73.14%

31 agosto, domingo